|
Antiplatelets
Citations 1-10 of 92 total displayed.
|
Most recent content
(29 Sep 2009):
|
- Editorials
Reducing Stroke Rates in Patients With Atrial Fibrillation: How Low Can We Go?
- Michael D. Ezekowitz, Meghashyam J. Koti, and Brian Fulton
Circulation 2009;120:1169-1170; published online before print as doi:10.1161/CIRCULATIONAHA.109.893438
[Full text]
|
Past content
(since Mar 2000):
|
- Articles
Reducing Stroke Rates in Patients With Atrial Fibrillation. How Low Can We Go?
- Michael D. Ezekowitz, Meghashyam J. Koti, and Brian Fulton
Circulation published September 14, 2009, doi:10.1161/CIRCULATIONAHA.109.893438
[Abstract]
- Clinician Update
Can We Override Clopidogrel Resistance?
- Ana Pena, Jean-Philippe Collet, Jean-Sébastien Hulot, Johanne Silvain, Olivier Barthélémy, Farzin Beygui, Christian Funck-Brentano, and Gilles Montalescot
Circulation 2009;119:2854-2857, doi:10.1161/CIRCULATIONAHA.108.857722
[Full text]
- AHA/ASA/ACCF Science Advisory
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory.
- Patrick T. O'Gara, Steven R. Messe, E. Murat Tuzcu, Gloria Catha, and John C. Ring
Circulation 2009;119:2743-2747; published online before print as doi:10.1161/CIRCULATIONAHA.109.192272
[Abstract]
[Full text]
- Articles
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention. A Call for Completion of Randomized Clinical Trials, A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation
- Patrick T. O'Gara, Steven R. Messe, E. Murat Tuzcu, Gloria Catha, and John C. Ring
Circulation published May 11, 2009, doi:10.1161/CIRCULATIONAHA.109.192272
[Abstract]
- Stroke
Aortic Arch Plaques and Risk of Recurrent Stroke and Death
- Marco R. Di Tullio, Cesare Russo, Zhezhen Jin, Ralph L. Sacco, J.P. Mohr, Shunichi Homma for the Patent Foramen Ovale in Cryptogenic Stroke Study Investigators
Circulation 2009;119:2376-2382; published online before print as doi:10.1161/CIRCULATIONAHA.108.811935
[Abstract]
[Full text]
- Articles
Aortic Arch Plaques and Risk of Recurrent Stroke and Death
- Marco R. Di Tullio, Cesare Russo, Zhezhen Jin, Ralph L. Sacco, J. P. Mohr, Shunichi Homma for the Patent Foramen Ovale in Cryptogenic Stroke Study Investigators
Circulation published April 20, 2009, doi:10.1161/CIRCULATIONAHA.108.811935
[Abstract]
- AHA Conference Proceedings
Atherosclerotic Peripheral Vascular Disease Symposium II: Stroke Intervention: State of the Art
- Mark J. Alberts, Robert A. Felberg, Lee R. Guterman, Steven R. Levine, and for Writing Group 4
Circulation 2008;118:2845-2851, doi:10.1161/CIRCULATIONAHA.108.191174
[Full text]
- Controversies in Cardiovascular Medicine
Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close? Closure: What Else!
- Stephan Windecker and Bernhard Meier
Circulation 2008;118:1989-1997, doi:10.1161/CIRCULATIONAHA.107.757013
[Full text]
- Coronary Heart Disease
Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk
- John W. Eikelboom, Graeme J. Hankey, Jim Thom, Deepak L. Bhatt, P. Gabriel Steg, Gilles Montalescot, S. Claiborne Johnston, Steven R. Steinhubl, Koon-Hou Mak, J. Donald Easton, Christian Hamm, Tingfei Hu, Keith A.A. Fox, Eric J. Topol on behalf of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators
Circulation 2008;118:1705-1712; published online before print as doi:10.1161/CIRCULATIONAHA.108.768283
[Abstract]
[Full text]
|
|
